Propel Global Bhd
KLSE:PGB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Propel Global Bhd
KLSE:PGB
|
MY |
|
Ascopiave SpA
MIL:ASC
|
IT |
|
Nath Bio-Genes (I) Ltd
NSE:NATHBIOGEN
|
IN |
|
G
|
Garuda Metalindo Tbk PT
IDX:BOLT
|
ID |
|
Bapcor Ltd
ASX:BAP
|
AU |
|
Nebius Group NV
NASDAQ:NBIS
|
NL |
|
A
|
Anand Rathi Wealth Ltd
NSE:ANANDRATHI
|
IN |
|
S
|
SIK Cheong Bhd
KLSE:SCB
|
MY |
|
Nusa Palapa Gemilang Tbk PT
IDX:NPGF
|
ID |
|
F
|
F I P P SA
XBER:FIPP
|
FR |
|
T
|
Tongxin International Ltd
OTC:TXIC
|
CN |
Balance Sheet
Balance Sheet Decomposition
Propel Global Bhd
Propel Global Bhd
Balance Sheet
Propel Global Bhd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
92
|
16
|
72
|
12
|
21
|
19
|
66
|
16
|
29
|
14
|
|
| Cash |
92
|
16
|
72
|
12
|
21
|
19
|
66
|
16
|
29
|
14
|
|
| Short-Term Investments |
52
|
53
|
0
|
49
|
26
|
29
|
3
|
24
|
15
|
8
|
|
| Total Receivables |
226
|
202
|
180
|
110
|
56
|
69
|
54
|
98
|
94
|
81
|
|
| Accounts Receivables |
170
|
125
|
99
|
82
|
44
|
60
|
53
|
77
|
80
|
70
|
|
| Other Receivables |
56
|
78
|
81
|
28
|
12
|
10
|
1
|
21
|
14
|
11
|
|
| Inventory |
24
|
24
|
17
|
16
|
14
|
13
|
9
|
9
|
9
|
7
|
|
| Other Current Assets |
7
|
26
|
8
|
20
|
10
|
3
|
0
|
7
|
3
|
0
|
|
| Total Current Assets |
401
|
322
|
277
|
207
|
127
|
134
|
132
|
154
|
138
|
102
|
|
| PP&E Net |
713
|
550
|
88
|
70
|
32
|
31
|
27
|
30
|
37
|
35
|
|
| PP&E Gross |
713
|
550
|
0
|
70
|
32
|
31
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
62
|
137
|
0
|
57
|
27
|
19
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
0
|
84
|
0
|
0
|
0
|
0
|
1
|
22
|
23
|
|
| Goodwill |
84
|
84
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
28
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
4
|
|
| Long-Term Investments |
25
|
12
|
11
|
11
|
10
|
5
|
12
|
6
|
7
|
21
|
|
| Other Long-Term Assets |
12
|
13
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
84
|
84
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1 264
N/A
|
981
-22%
|
461
-53%
|
290
-37%
|
170
-41%
|
171
+1%
|
172
+0%
|
193
+12%
|
207
+7%
|
185
-11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
130
|
107
|
52
|
116
|
95
|
108
|
44
|
34
|
33
|
22
|
|
| Accrued Liabilities |
14
|
28
|
0
|
30
|
33
|
31
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
28
|
16
|
18
|
22
|
8
|
5
|
3
|
3
|
0
|
2
|
|
| Current Portion of Long-Term Debt |
122
|
26
|
108
|
210
|
194
|
172
|
9
|
5
|
3
|
7
|
|
| Other Current Liabilities |
125
|
98
|
83
|
44
|
43
|
32
|
10
|
30
|
44
|
30
|
|
| Total Current Liabilities |
420
|
276
|
261
|
422
|
372
|
348
|
66
|
71
|
80
|
61
|
|
| Long-Term Debt |
544
|
618
|
111
|
3
|
1
|
24
|
26
|
28
|
18
|
26
|
|
| Deferred Income Tax |
4
|
3
|
5
|
2
|
1
|
0
|
0
|
1
|
0
|
1
|
|
| Minority Interest |
36
|
36
|
37
|
16
|
2
|
17
|
0
|
7
|
8
|
6
|
|
| Other Liabilities |
0
|
0
|
33
|
0
|
0
|
0
|
4
|
3
|
2
|
1
|
|
| Total Liabilities |
1 004
N/A
|
932
-7%
|
448
-52%
|
442
-1%
|
376
-15%
|
389
+4%
|
96
-75%
|
110
+14%
|
107
-2%
|
95
-12%
|
|
| Equity | |||||||||||
| Common Stock |
174
|
185
|
271
|
271
|
271
|
271
|
121
|
121
|
132
|
138
|
|
| Retained Earnings |
28
|
177
|
258
|
417
|
467
|
482
|
46
|
38
|
32
|
54
|
|
| Additional Paid In Capital |
71
|
71
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Unrealized Security Profit/Loss |
9
|
6
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
6
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
22
|
37
|
0
|
7
|
11
|
8
|
0
|
0
|
0
|
0
|
|
| Total Equity |
260
N/A
|
49
-81%
|
13
-73%
|
152
N/A
|
206
-35%
|
218
-6%
|
75
N/A
|
83
+10%
|
99
+20%
|
90
-9%
|
|
| Total Liabilities & Equity |
1 264
N/A
|
981
-22%
|
461
-53%
|
290
-37%
|
170
-41%
|
171
+1%
|
172
+0%
|
193
+12%
|
207
+7%
|
185
-11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 736
|
1 853
|
2 043
|
2 043
|
2 043
|
2 043
|
604
|
604
|
676
|
734
|
|